Literature DB >> 17401741

Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies.

Adrián Arés-Luque, L A García-Tuñón, A Saiz, B C Cabezas, L E Hernández-Echebarría, M Franco, A Toribio, J Tejada, F Graus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17401741     DOI： 10.1007/s00415-006-0471-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

2.  Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.

Authors:  F Bernal; S Shams'ili; I Rojas; R Sanchez-Valle; A Saiz; J Dalmau; J Honnorat; P Sillevis Smitt; F Graus
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

3.  Paraneoplastic optic neuropathy in nasopharyngeal carcinoma--report of a case.

Authors:  S T Hoh; M Teh; S J Chew
Journal:  Singapore Med J       Date:  1991-04       Impact factor: 1.858

Review 4.  Paraneoplastic syndromes affecting the nervous system.

Authors:  J O Dalmau; J B Posner
Journal:  Semin Oncol       Date:  1997-06       Impact factor: 4.929

5.  Lung cancer with visual loss.

Authors:  E B Ing; J J Augsburger; R C Eagle
Journal:  Surv Ophthalmol       Date:  1996 May-Jun       Impact factor: 6.048

6.  CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.

Authors:  Z Yu; T J Kryzer; G E Griesmann; K Kim; E E Benarroch; V A Lennon
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

7.  Paraneoplastic optic neuropathy in a patient with a non-small cell lung carcinoma: a case report.

Authors:  I C Asproudis; A N Nikas; K G Psilas
Journal:  Eur J Ophthalmol       Date:  2005 May-Jun       Impact factor: 2.597

Review 8.  Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.

Authors:  Shelley A Cross; Diva R Salomao; Joseph E Parisi; Thomas J Kryzer; Elizabeth A Bradley; Jonathan A Mines; Byron L Lam; Vanda A Lennon
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

9.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

10.  Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.

Authors:  K Peterson; M K Rosenblum; H Kotanides; J B Posner
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910
View more
  3 in total

Review 1.  Atypical Optic Neuritis.

Authors:  Eric D Gaier; Katherine Boudreault; Joseph F Rizzo; Julie Falardeau; Dean M Cestari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

2.  Anti-Collapsing Response-Mediating Protein-5 Antibody-Positive Paraneoplastic Perioptic Neuritis without Typical Neurological Symptoms.

Authors:  Nozomi Igarashi; Hiromasa Sawamura; Toshikatsu Kaburaki; Makoto Aihara
Journal:  Neuroophthalmology       Date:  2016-10-27

3.  Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma.

Authors:  Emmanouel Saloustros; Ioannis Zaganas; Michail Mavridis; Lambros Vamvakas; Andreas Plaitakis; Vassilis Georgoulias; Dimitris Mavroudis
Journal:  J Neurooncol       Date:  2009-10-02       Impact factor: 4.130
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.